|
⚲
|
| Keyboard |
| Stein Evan A
✚
|
|
|---|---|
| CIK # | 0001620461 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001620461] | |
| 4 | [0001620461] | |
| SC 13G | [0001620461] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Stein Evan A | Xenon Pharmaceuticals Inc | [2015-02-17] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| CymaBay Therapeutics Inc | |
| Stein Evan A | |
| Xenon Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
CymaBay Therapeutics Inc CBAY
Stock Option (right to buy) · derivative
|
2019-01-29 | Grant | 27,705 | $0.00 | |
|
CymaBay Therapeutics Inc CBAY
Stock Option (right to buy) · derivative
|
2018-01-24 | Grant | 16,000 | $0.00 | |
|
CymaBay Therapeutics Inc CBAY
Stock Option (right to buy) · derivative
|
2017-09-22 | Grant | 7,500 | $0.00 | |
|
CymaBay Therapeutics Inc CBAY
Stock Option (right to buy) · derivative
|
2017-06-28 | Grant | 15,000 | $0.00 | |
|
CymaBay Therapeutics Inc CBAY
Stock Option (right to buy) · derivative
|
2017-01-19 | Grant | 12,000 | $0.00 | |
|
CymaBay Therapeutics Inc CBAY
Stock Option (right to buy) · derivative
|
2016-04-26 | Grant | 18,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2015-04-30 | Other | 1,038,964 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2015-04-30 | Other | 909,619 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2015-04-30 | Other | 4,172 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Series B Preferred Shares · derivative
|
2014-11-09 | Conversion | 967 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Series E Preferred Shares · derivative
|
2014-11-09 | Conversion | 1,038,964 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2014-11-09 | Conversion | 967 | ||
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2014-11-09 | Conversion | 1,038,964 | ||
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy · derivative
|
2014-11-04 | Grant | 5,144 | $0.00 |